Poul Schmith advised the shareholders of Azanta A/S and the company throughout the process and the negotiations with Norgine B.V.
Azanta A/S, a specialty biopharmaceutical company operating within women’s healthcare, addiction medicine and oncology. The company is headquartered in Denmark and with subsidiaries across the Nordic countries and France. Azanta A/S is the company behind i.a. the product Angusta ® for labour induction.
The team advising on the transaction was Carina Vang Kristoffersen, Esben Ravnsbæk Johannsen and Line Vittrup Lauridsen.
